Position in XNCR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,924,033
+$868,274 QoQ
Shares Held
181,617
+6.5% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 208 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. XNCR ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in XNCR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,924,033 | 181,617 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,055,759 | 170,461 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,538,352 | 165,797 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,062,708 | 175,849 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,386,535 | 176,404 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,743,438 | 163,857 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,906,600 | 170,000 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $3,061,888 | 152,257 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,926,066 | 154,573 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,326,316 | 150,308 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,923,962 | 184,831 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,626,375 | 179,969 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,455,422 | 178,431 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,185,671 | 185,933 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,562,728 | 175,220 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,571,830 | 175,975 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,677,751 | 170,908 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,926,308 | 147,163 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,476,941 | 136,514 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,515,865 | 138,269 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,490,256 | 159,184 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $7,140,080 | 165,817 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,162,649 | 164,168 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $6,435,183 | 165,898 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,485,732 | 169,365 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,179,996 | 173,360 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||